Impact of setmelanotide on metabolic syndrome risk in patients with proopiomelanocortin or leptin receptor deficiencies.
- DOI
- 10.1210/clinem/dgag345
- Published
- 2026 Oct 19
- Container
- The Journal of clinical endocrinology and metabolism
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1210/clinem/dgag345,
title = {Impact of setmelanotide on metabolic syndrome risk in patients with proopiomelanocortin or leptin receptor deficiencies.},
author = {Wabitsch M and Farooqi IS and Chung WK and van den Akker E and Kühnen P and Swain J and Garrison JC and Touchot N and Argente J and Clément K},
year = {2026},
journal = {The Journal of clinical endocrinology and metabolism},
doi = {10.1210/clinem/dgag345},
url = {https://doi.org/10.1210/clinem/dgag345}
}RIS
TY - JOUR TI - Impact of setmelanotide on metabolic syndrome risk in patients with proopiomelanocortin or leptin receptor deficiencies. AU - Wabitsch M AU - Farooqi IS AU - Chung WK AU - van den Akker E AU - Kühnen P AU - Swain J AU - Garrison JC AU - Touchot N AU - Argente J AU - Clément K PY - 2026 JO - The Journal of clinical endocrinology and metabolism DO - 10.1210/clinem/dgag345 UR - https://doi.org/10.1210/clinem/dgag345 ER -
APA
M, W., IS, F., WK, C., E, V. D. A., P, K., J, S., JC, G., N, T., J, A., & K, C. (2026). Impact of setmelanotide on metabolic syndrome risk in patients with proopiomelanocortin or leptin receptor deficiencies.. The Journal of clinical endocrinology and metabolism. https://doi.org/10.1210/clinem/dgag345
Source records
- pubmed · retrieved 2026-11-10T20:38:47.594Z